Yutaka Matsuda

1.9k citations
69 papers · 1.5k indexed · h-index 25

Yutaka Matsuda

62 papers receiving 1.5k citations

Peers

Yutaka Matsuda
Comparison fields: 5 of 101
  • Radiology, Nuclear Medicine and Imaging 664
  • Oncology 722
  • Molecular Biology 842
  • Organic Chemistry 255
  • Immunology and Allergy 48
Replace Olga V. Glinskii with:
Olga V. Glinskii United States
Mathew Robson United Kingdom
Jason Cameron Denmark
Jieyi Wang United States
Liqiang Pan China
Xiaoyang Zheng United States
Attila Bíró Hungary
Lopamudra Das Roy United States
Matteo Villain United States
Yutaka Matsuda relative to Olga V. Glinskii United States Olga V. Glinskii's profile →
Citations per field
00.5×6.4×
Olga V. Glinskii · 1×
Citations per year

Countries citing papers authored by Yutaka Matsuda

Since Specialization
Citations

This map shows the geographic impact of Yutaka Matsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Matsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Matsuda more than expected).

Fields of papers citing papers by Yutaka Matsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Matsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Matsuda. The network helps show where Yutaka Matsuda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yutaka Matsuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yutaka Matsuda Line = papers co-authored together Yutaka Matsuda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20251
3 20250
4 20241
5 20241
6 20234
7 202342
8 20237
9 20230
10 202210
11 202124
12 202125
13 202026
14 202028
15 201916
16 2013128
17 2009128
18 2007176
19 200112
20 200016

About Yutaka Matsuda

Yutaka Matsuda is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Organic Chemistry, having authored 69 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (37 papers), HER2/EGFR in Cancer Research (27 papers), Click Chemistry and Applications (12 papers), Nanofabrication and Lithography Techniques (7 papers), Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (6 papers), Protein purification and stability (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (664 citations), Oncology (722 citations) and Molecular Biology (842 citations). Yutaka Matsuda has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Brian A. Mendelsohn, Thomas Schlange, Nancy E. Hynes, Kei Yamada, Susanne Lienhard, Alexandre Huber, Tomohiro Fujii, Tatsuya Okuzumi, Kazutaka Shimbo and Edward J. Oakeley. Their work appears in journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026